New: Introducing the Finviz Crypto Map

Learn More

Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint

By Angelica Ballesteros | July 30, 2025, 8:05 AM

We recently published Massive Drop Alert: These 10 Stocks Take a Beating. Exelixis, Inc. (NASDAQ:EXEL) is one of the worst-performing stocks on Tuesday.

Exelixis nosedived by 16.78 percent on Tuesday to close at $36.94 apiece as investors took path from a dismal earnings performance in the second quarter of the year.

In its earnings release, Exelixis, Inc. (NASDAQ:EXEL) said net income during the period dropped by 18 percent to $185 million from $226 million in the same period last year.

Exelixis (EXEL) Tumbles 16.8% as Q2 Earnings Disappoint
Photo by National Cancer Institute on Unsplash

Revenues, on the other hand, dropped by 10.8 percent to $568 million from $637 million year-on-year.

For the full-year period, Exelixis, Inc. (NASDAQ:EXEL) expects total revenues to end between $2.25 billion and $2.35 billion, while net product revenues are projected to settle at a range of $2.05 billion to $2.15 billion.

Commenting on the performance, Exelixis, Inc. (NASDAQ:EXEL) said that the company “continued to execute on our corporate objectives in the second

While we acknowledge the potential of EXEL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

Mentioned In This Article

Latest News